Glenn Larsen

Chief Executive Officer at

Aquinnah Pharmaceuticals, Inc.

Net worth: 730 249 $ as of 31/05/2026

72 year

29 connections

Health Technology

Retail Trade

Consumer Services

Profile

Glenn R.
Larsen is the founder of Aquinnah Pharmaceuticals, Inc., founded in 2014, serving as Chairman, President & Chief Executive Officer.
Dr. Larsen was the founder of 180 Therapeutics LP, founded in 2013, serving as Chairman from 2013 to 2020.
Former jobs include Senior Director at Genetics Institute LLC from 2003 to 2010; COO, Director & Executive VP-Development at Hydra Biosciences, Inc. from 2003 to 2010; Independent Director at Anika Therapeutics, Inc. from 2015 to 2026; Vice President at Wyeth Pharmaceuticals LLC; and CSO, Executive VP-Research & Development at SpringLeaf Therapeutics, Inc. from 2012 to 2013.
Education includes a doctorate from Stony Brook University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ANIKA THERAPEUTICS, INC. 0.38%	21/04/2026	50,258 ( 0.38% )	730 249 $	31/05/2026

Glenn Larsen active positions

Companies	Position	Start
Aquinnah Pharmaceuticals, Inc. Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules	Chief Executive Officer	01/02/2014

All active positions of Glenn Larsen

Former positions of Glenn Larsen

Companies	Position	End
ANIKA THERAPEUTICS, INC.	Director/Board Member	18/06/2026
180 Therapeutics LP 180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Engages in development of biological therapies for the treatment of fibrosis	Founder	01/01/2020
SpringLeaf Therapeutics, Inc. SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade Develops various drug delivery technologies	Chief Tech/Sci/R&D Officer	01/01/2013
Hydra Biosciences, Inc. Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases	Chief Tech/Sci/R&D Officer	01/01/2010
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Director/Board Member	01/01/2010

See the detail of Glenn Larsen's experience

Training of Glenn Larsen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Glenn Larsen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Genetics Institute LLC Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
Anika Therapeutics, Inc. Anika Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair	Health Technology
Wyeth Pharmaceuticals LLC Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products	Health Technology
SpringLeaf Therapeutics, Inc. SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade Develops various drug delivery technologies	Retail Trade
Stony Brook University Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hydra Biosciences, Inc. Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases	Health Technology
Aquinnah Pharmaceuticals, Inc. Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development to modulate neurodegenerative stress granules	Health Technology
180 Therapeutics LP 180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Engages in development of biological therapies for the treatment of fibrosis	Health Technology